Actively Recruiting
Long-Term Study of Live Attenuated Herpes Zoster Vaccine Effectiveness in Adults 40 Years and Older
Led by Jiangsu Province Centers for Disease Control and Prevention · Updated on 2026-05-13
24740
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the long-term effectiveness of a live attenuated herpes zoster vaccine in adults aged 40 years or older. This multicenter retrospective cohort study focuses on participants from a previous Phase III Clinical Trial conducted in 2020-2021, comparing those who originally received the vaccine with those who received a placebo. The study aims to assess the occurrence of herpes zoster over a period of up to six years after vaccination, including the impact of catch-up vaccination given after the vaccines marketing authorization in China.
CONDITIONS
Brief Title
Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine
Research Team
P
Pengfei Jin
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here